ACT-774312

· Idorsia Pharmaceuticals Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ACT-774312, covering 2022-02-01 to 2022-02-01. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate the Effect of ACT-774312 in Subjects With Bilateral Nasal Polyposis [Phase 2]